← United States · Coverage record
US · SEC FORM 4
Edwards Lifesciences Corp
EW · NYSE · CIK 0001099800 · Healthcare · Medical Devices
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
97 Form 4 transaction lines observed in the same window
26 sales · 71 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 2 additional owner(s) remain in Form 4 evidence.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2024-05-06 · Zovighian Bernard J.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 9,538,735
- Previous report
- 9,088,401
- Avg daily volume
- 3,875,387
- Days to cover
- 2.5
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2024-05-06 | Zovighian Bernard J | Purchase (P) | Common Stock | 580 | USD 85.74 | USD 49,751 | SEC filing ↗ |
| 2021-11-24 | VALERIANI NICHOLAS J | Purchase (P) | Common Stock | 1,500 | USD 112.23 | USD 168,345 | SEC filing ↗ |
Form 4 evidence
150 transaction lines in the latest 365-day window; 1,420 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-08 | Lippis Daniel J. | Sale (S) | Common Stock | 619 | USD 85.65 | USD 53,017 | SEC filing ↗ |
| 2026-10-08 | Lippis Daniel J. | Option exercise / conversion (M) | Common Stock | 619 | USD 72.68 | USD 44,989 | SEC filing ↗ |
| 2026-09-14 | Markowitz Wayne | Tax withholding (F) | Common Stock | 568 | USD 84.37 | USD 47,922 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-08 | Lippis Daniel J. | Sale (S) | Common Stock | 619 | USD 85.65 | USD 53,017 | SEC filing ↗ |
| 2026-10-08 | Lippis Daniel J. | Option exercise / conversion (M) | Common Stock | 619 | USD 72.68 | USD 44,989 | SEC filing ↗ |
| 2026-09-14 | Markowitz Wayne | Tax withholding (F) | Common Stock | 568 | USD 84.37 | USD 47,922 | SEC filing ↗ |
| 2026-09-13 | Dahl Andrew M. | Tax withholding (F) | Common Stock | 253 | USD 84.37 | USD 21,346 | SEC filing ↗ |
| 2026-09-11 | Markowitz Wayne | Tax withholding (F) | Common Stock | 355 | USD 86.77 | USD 30,803 | SEC filing ↗ |
| 2026-09-11 | Lippis Daniel J. | Sale (S) | Common Stock | 619 | USD 87.51 | USD 54,169 | SEC filing ↗ |
| 2026-09-11 | Lippis Daniel J. | Option exercise / conversion (M) | Common Stock | 619 | USD 72.68 | USD 44,989 | SEC filing ↗ |
| 2026-09-11 | Chopra Daveen | Tax withholding (F) | Common Stock | 398 | USD 86.77 | USD 34,534 | SEC filing ↗ |
| 2026-08-31 | Dahl Andrew M. | Sale (S) | Common Stock | 544 | USD 91.06 | USD 49,537 | SEC filing ↗ |
| 2026-08-28 | Bruls Annette | Sale (S) | Common Stock | 2,644 | USD 89.98 | USD 237,907 | SEC filing ↗ |
| 2026-08-26 | Markowitz Wayne | Sale (S) | Common Stock | 1,240 | USD 91.47 | USD 113,423 | SEC filing ↗ |
| 2026-08-26 | Chopra Daveen | Sale (S) | Common Stock | 31,800 | USD 91.02 | USD 2,894,371 | SEC filing ↗ |
| 2026-08-26 | Chopra Daveen | Option exercise / conversion (M) | Common Stock | 31,800 | USD 72.68 | USD 2,311,224 | SEC filing ↗ |
| 2026-08-11 | Lippis Daniel J. | Sale (S) | Common Stock | 619 | USD 92.03 | USD 56,967 | SEC filing ↗ |
| 2026-08-11 | Lippis Daniel J. | Option exercise / conversion (M) | Common Stock | 619 | USD 72.68 | USD 44,989 | SEC filing ↗ |
| 2026-07-30 | Markowitz Wayne | Sale (S) | Common Stock | 146 | USD 86.03 | USD 12,587 | SEC filing ↗ |
| 2026-07-28 | Markowitz Wayne | Sale (S) | Common Stock | 9,628 | USD 85.06 | USD 818,958 | SEC filing ↗ |
| 2026-07-28 | Markowitz Wayne | Option exercise / conversion (M) | Common Stock | 9,628 | USD 74.02 | USD 712,665 | SEC filing ↗ |
| 2026-07-27 | Zovighian Bernard J | Sale (S) | Common Stock | 2,921 | USD 83.93 | USD 245,122 | SEC filing ↗ |
| 2026-07-27 | Zovighian Bernard J | Gift (G) | Common Stock | 320 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-11 | Bruls Annette | Tax withholding (F) | Common Stock | 109 | USD 92.21 | USD 10,051 | SEC filing ↗ |
| 2026-07-10 | Lippis Daniel J. | Sale (S) | Common Stock | 619 | USD 91.70 | USD 56,762 | SEC filing ↗ |
| 2026-07-10 | Lippis Daniel J. | Option exercise / conversion (M) | Common Stock | 619 | USD 72.68 | USD 44,989 | SEC filing ↗ |
| 2026-07-09 | Mistras Theodora | Award / grant (A) | Common Stock | 99,920 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-07 | Lippis Daniel J. | Tax withholding (F) | Common Stock | 377 | USD 95.18 | USD 35,883 | SEC filing ↗ |
| 2026-06-30 | Lippis Daniel J. | Sale (S) | Common Stock | 619 | USD 91.40 | USD 56,577 | SEC filing ↗ |
| 2026-06-30 | Lippis Daniel J. | Option exercise / conversion (M) | Common Stock | 619 | USD 72.68 | USD 44,989 | SEC filing ↗ |
| 2026-06-17 | Zovighian Bernard J | Sale (S) | Common Stock | 523 | USD 87.92 | USD 45,982 | SEC filing ↗ |
| 2026-05-29 | Dahl Andrew M. | Sale (S) | Common Stock | 568 | USD 86.08 | USD 48,853 | SEC filing ↗ |
| 2026-05-27 | BOBO DONALD E JR | Sale (S) | Common Stock | 23,145 | USD 86.42 | USD 2,000,191 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-19 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | EW |
| CIK | 0001099800 |
| Sector | Healthcare |
| Industry | Medical Devices Yahoo Finance |
| SEC SIC | 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Exchange | NYSE |
Data coverage
| Local Form 4 history | 1,420 transaction lines from 2020-01-02 to 2026-10-08 2 P purchase lines · 585 S sale lines · 833 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.